- Saturday, September 26, 2009, 14:42
- U.S. News
- 117 views
Burnham Institute for Medical Research (Burnham) has appointed Michael R. Jackson, Ph.D., to the newly created position of Vice President for Drug Discovery and Development. In this role, Dr. Jackson will oversee the chemical biology and drug discovery efforts of the Conrad Prebys Center for Chemical Genomics (CPCCG) at Burnhamâs La Jolla, California and Orlando, Florida campuses. He will lead Burnhamâs efforts to identify ...
Full story
- Saturday, September 26, 2009, 14:42
- U.S. News
- 64 views
LAB Research Inc. (âLABâ, âLAB Researchâ or the âCompanyâ), (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced the nomination of Dr. Daniel P. MĂ©nard as the new President for LAB Research Canada. Dr. MĂ©nard will assume full responsibility of LAB Research Canada overall performance.
âWe are thrilled to welcome Dr. MĂ©nard to LAB Research Canada. Daniel is the perfect candidate to take over ...
Full story
- Saturday, September 26, 2009, 14:42
- U.S. News
- 38 views
Semafore Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics targeting the phosphoinositide-3-kinase (PI3K) pathway for the treatment of cancer and other serious diseases, announced today that its board of directors has named Michael D. Becker as the companyâs acting chief executive officer.
Mr. Becker continues as CEO of MD Becker Partners LLC, a boutique management and strategy ...
Full story
- Saturday, September 26, 2009, 14:42
- U.S. News
- 57 views
Merrimack Pharmaceuticals, Inc., announced today that Clet Niyikiza, Ph.D., has joined the company as Senior Vice President, Development. Dr. Niyikiza comes to Merrimack from GlaxoSmithKline (GSK) where he was Vice President and Medicine Development Leader for oncology. Dr. Niyikiza has extensive drug development experience with a career that spans over 18 years in the pharmaceutical industry in which he has led ten New Drug Application ...
Full story
- Saturday, September 26, 2009, 14:42
- U.S. News
- 39 views
MEDNETWorld.com (MEDNET), a leader in Nationwide Health Information Network (NHIN) connectivity and Health Information Exchange (HIE) technologies today announced the appointment of Michael Howe, former CEO of MinuteClinic and Arbyâs, Inc., to its board of directors. Mr. Howe brings extensive health care and operational expertise to MEDNET from his experience at MinuteClinic.
âIâm pleased to join the MEDNET Board of Directors,â said Howe. âMEDNET has the ...
Full story
- Saturday, September 26, 2009, 11:32
- U.S. News
- 24 views
The rate of strokes in infants and children may be much higher than originally thought, it is believed.
A new study has found that stroke rates in younger individuals may be much more common than previously identified.
According to a recent report by Heather J Fullerton, an associate professor of neurology at the University of California, San Francisco, imaging studies and diagnostic codes now show there to ...
Full story
- Saturday, September 26, 2009, 11:32
- U.S. News
- 60 views
Drug makers can only produce enough H1N1 vaccine each year for half the planet and each country will have to decide who should get the limited supplies, the World Health Organization (WHO) said Thursday.
The H1N1 vaccine looks to be as safe as the regular flu shot it said in a statement estimating that drug makers worldwide can produce an estimated 3 billion doses per year.
A ...
Full story
- Saturday, September 26, 2009, 11:32
- U.S. News
- 60 views
The conclusion follows a review by Sarah Pendlebury and Peter Rothwell at Oxford Universityâs Stroke Prevention Research Unit of studies published between 1950 and May this year.
They found that multiple strokes and the complications and characteristics of the stroke itself are more important predictors of post-stroke dementia than underlying vascular risk factors, and that the burden of dementia can be reduced by providing the best ...
Full story
- Saturday, September 26, 2009, 11:32
- U.S. News
- 79 views
The results of the poll suggest that only 58 per cent of people with asthma are planning to have the swine flu vaccine. A further 25 per cent said they were still undecided over whether to have the vaccine or not, when it becomes available â probably next month. However, at least 17 per cent would reject it.
The charity has recommended strongly that people with ...
Full story
- Saturday, September 26, 2009, 10:34
- U.S. News
- 28 views
The team from the University of Edinburgh said previous research had thrown up conflicting causes for the global rise in preterm birth.
They looked at Scottish data on 90,000 preterm births over the past 25 years.
They found the absolute increase in the rate of preterm births was similar in each group â 4.24 per 1,000 births for medically induced compared with 4.71 for spontaneous.
Writing in the ...
Full story